INTERCEPT PHARMACEUTICALS IN (ICPT)

US45845P1084 - Common Stock

19  +0.04 (+0.21%)

After market: 19 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
317.68M285.71M260.75M312.70M252.00M
Cost Of Goods
632.00K984.00K1.21M5.30M4.20M
Gross Profit
317.05M284.73M259.55M307.40M247.80M
Operating Expenses
372.15M352.94M360.24M526.00M560.20M
Research and Development
160.42M176.64M182.75M191.50M242.80M
Selling, General, and Administrative Expenses
211.73M176.30M177.49M334.50M317.40M
Operating Income
-55.09M-68.22M-100.69M-218.60M-312.40M
Interest Income/Expense
-10.23M-21.39M-54.42M-48.10M-41.10M
Other Income/Expense
14.16M6.52M1.96M4.40M8.90M
Non Recurring Items
N/A-91.78M16.80M-12.60MN/A
Income Before Taxes
-57.47M-174.86M-136.35M-274.90M-344.70M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-61.61M221.82M-91.43M-274.90M-344.70M
EBITDA
-54.72M-67.62M-97.88M-215.48M-308.74M
 
Per Share Data
EPS Diluted Total Ops
-1.476.55-2.86-8.34-10.89
Non GAAP EPS
-1.336.04-3.41-7.97-10.89
 
Statistics
Gross Profit Margin
99.80%99.66%99.54%98.31%98.33%
Profit Margin
-19.39%77.64%-35.06%-87.91%-136.79%
Operating Profit Margin
-17.34%-23.88%-38.62%-69.91%-123.97%

All data in USD

Charts